Related Experiment Videos
Urologic applications of a permanent, epithelializing urethral endoprosthesis
1Department of Urology, Mayo Clinic, Rochester, Minnesota.
Urology
|January 1, 1993
Summary
A new UroLume Wallstent shows promise for treating urethral strictures, benign prostatic hyperplasia, and detrusor-external sphincter dyssynergia with minimal side effects.
Area of Science:
- Urology
- Medical Devices
- Endovascular Surgery
Background:
- Arterial stenosis often requires interventions like balloon angioplasty.
- Maintaining vessel patency after angioplasty is crucial for treatment success.
- Existing treatments may have limitations in managing specific urological conditions.
Purpose of the Study:
- To evaluate the efficacy and safety of the UroLume Wallstent.
- To assess the potential of this endoprosthesis in treating recurrent bulbar urethral strictures.
- To investigate its application in benign prostatic hyperplasia and detrusor-external sphincter dyssynergia.
Main Methods:
- A flexible, self-expanding, permanent endoprosthesis (UroLume Wallstent) was investigated.
- The device was studied in patients with recurrent bulbar urethral strictures.
- Its use in benign prostatic hyperplasia and detrusor-external sphincter dyssynergia was also examined.
Main Results:
- Preliminary data indicate the UroLume Wallstent is effective for the studied urological conditions.
- The device demonstrated minimal adverse effects in select patients.
- Positive outcomes were observed across all three investigated indications.
Conclusions:
- The UroLume Wallstent shows potential as an effective treatment for specific urological conditions.
- This endoprosthesis may offer a significant advancement in urological treatment options.
- Further long-term studies are warranted to confirm these encouraging preliminary findings.